Two poster presentations at ACNP highlight new research on the fundamental biology of molecules targeting synaptic function in CNS disease Insights advance translational model supporting Gate’s lead ...
INDIANAPOLIS, December 12, 2024--(BUSINESS WIRE)--Gate Neurosciences, a synaptic health biotechnology company focused on advancing next-generation precision central nervous system (CNS) treatments, ...